Benzalkonium Completed Phase 4 Trials for Glaucoma, Primary Open Angle (POAG) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03104621Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients